Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Goodness Growth Extends Expungement Efforts With Three Free Clinics

By Vuk Zdinjak
November 17, 10:57 AM
Goodness Growth Holdings, Inc. (OTCQX: GDNSF) (CSE:GDNS) , a physician-led, science-focused cannabis company and IP developer, has continued its efforts to help individuals impacted by non-violent cannabis convictions with three free expungement clinics.

CSE:GDNS

Read More
1 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Vext Science Revenue Declines 18% YoY, What About Adjusted EBITDA?

By Vuk Zdinjak
November 17, 9:23 AM
Vext Science, Inc. (OTCQX: VEXTF) (CSE:VEXT) revenue in the Q3 2022 was $7.7 million, a decrease of 18% compared to $9.4 million in Q3 2021, and a decrease of 12% compared to 8.8 million in Q2 2022.

CSE:VEXT

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Psychedelics
  • Small Cap

Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS’ Latest Trial Outcomes

By Lara Goldstein
Today, 7:57 PM
(Part one of a four-part series)

CMPS

Read More
2 minute read
  • Cannabis
  • Exclusives
  • Markets
  • News
  • Penny Stocks
  • Retail Sales

EXCLUSIVE: Holiday Cannabis Shopping Trends And Deals According To Weedmaps Data

By Nicolas Jose Rodriguez
Today, 7:45 PM
End-of-the-year holidays, such as Thanksgiving, Black Friday and Green Wednesday are recognized as some of the biggest days for cannabis deals and sales.

MAPS

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Small Cap

GrowGeneration Announces Partnership With Grodan Becoming A Platinum Certified Distributor

By Joana Scopel
Today, 7:33 PM
GrowGeneration Corp. (NASDAQ: GRWG) the largest chain of specialty hydroponic and organic garden centers with 58 locations across 15 states, reported

GRWG

Read More
2 minute read
  • After-Hours Center
  • Cannabis
  • Cryptocurrency
  • Markets
  • News

FTX Crypto Collapse And Bitcoin Bankruptcies Got You Down? Cannabis Can Help Anxiety, Say Studies

By Maureen Meehan
Today, 5:47 PM
FTX’s stunning collapse not only left employees “sick with anger,” but the company may also have more than one million creditors, rather than its initially stated 100,000, according to information in a Tuesday bankruptcy f

$FTT

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon

By Lara Goldstein
Today, 12:47 PM
Canadian clinical-stage psychedelics company Algernon Pharmaceuticals Inc.

AGNPF

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Another Cannabis Co. To Build Growing Facility In Michigan, Here Are The Details

By Jelena Martinovic
Today, 11:52 AM
Hero Technologies (OTCQB: HENC) plans to build a local cannabis growing facility in Michigan.

HENC

Read More
3 minute read
  • Cannabis
  • Education
  • General
  • Health Care
  • Markets
  • News

Think Twice Before Puffing: Why Smoking Marijuana Might Be More Harmful To Lungs Than Tobacco, New Evidence

By Jelena Martinovic
Today, 11:50 AM
With cannabis being set free from a decades-long stigma and its recreational and medical use more widespread, the question arises: is smoking weed dangerous?

CSE:TRUL

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Skye Initiates First-in-Human Phase 1 Clinical Trial For Cannabinoid Based Drug For Treatment Of Glaucoma

By Vuk Zdinjak
Today, 11:28 AM
Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has initiated screening for its first-in-human Phase 1 trial of SBI-100 Ophthalmic Emulsion.

SKYE

Posts pagination

Previous 1 … 352 353 354 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service